Huang James's Form 4 filing
Atara Biotherapeutics, Inc. (ATRA) · filed Jan 14, 2026
- Accession no.
- 0001193125-26-013358
- Filed
- Jan 14, 2026, 9:16 PM ET
- Trade date
- Jan 12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $489.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Huang JamesCIK 0001573160 | Director, 10% Owner |
| Panacea Innovation LtdCIK 0002010692 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Common Stock | SSaleDisposed | −80,554 | $6.07 | −$489,019.17 | 1,324,446 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.